Magnesium Sulphate Phoenix Labs

Magnesium sulfate, the active ingredient in Magnesium Sulphate Phoenix Labs, is a magnesium salt presented as an injection for intramuscular and intravenous use. It is employed to treat eclampsia, severe preeclampsia, magnesium deficiency, torsades de pointes prophylaxis, and asthma exacerbations.

GNH USA supplies Magnesium Sulphate Phoenix Labs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium sulfate is used in obstetric, cardiac and respiratory conditions where electrolyte balance or neuromuscular control is critical. - Eclampsia: prevents and controls seizures in pregnant women with this condition. - Severe preeclampsia: stabilises blood pressure and reduces risk of convulsions. - Magnesium deficiency: restores normal serum magnesium levels. - Torsades de pointes prophylaxis: reduces the incidence of ventricular arrhythmias. - Asthma exacerbations: assists bronchodilation and improves airway responsiveness.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Flushing or warmth at the injection site. - Nausea or vomiting. - Headache. - Mild hypotension. - Muscle weakness or fatigue.

Serious or Rare Side Effects: - Respiratory depression or arrest. - Severe hypotension leading to shock. - Cardiac arrhythmias, including bradycardia. - Hypermagnesemia with neuromuscular paralysis. - Anaphylactic or severe allergic reactions.

Magnesium sulfate requires careful monitoring of patient status and laboratory values. - Serum magnesium monitoring: check levels before and during therapy to avoid toxicity. - Renal function assessment: adjust use in patients with impaired clearance. - Neuromuscular disease caution: patients with myasthenia gravis may experience exaggerated blockade. - Avoid rapid IV bolus: administer slowly to reduce cardiovascular effects. - Contraindicated in heart block without a pacemaker: may worsen conduction. - Store at below 25°C: keep in original container, protect from moisture and light.

Magnesium sulfate can alter the activity of several co‑administered medicines.

Major Interactions (Avoid): - Calcium channel blockers: additive vasodilatory effect may cause profound hypotension. - Neuromuscular blocking agents: potentiates blockade, risking respiratory failure. - Other magnesium‑containing products: risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance renal effects and potassium shifts. - Loop diuretics: increase magnesium loss, requiring dose adjustments. - Aminoglycoside antibiotics: may intensify neuromuscular weakness.